journal article·2025-10Open access

Single‐Cell RNA Sequencing Reveals the Heterogeneity in Differentiation Trajectory and Tumor Microenvironment Leading to More Aggressive Phenotypes of Papillary Thyroid Cancer in Children and Young Adult Patients

Kai Guo, Lingyi Yang, Zirui Huang, Kai Qian, Yuan Shi, Mengjia Fei, Yuan Feng, Zixian Chen, Ming Qiu, Linglin Tang, Anqi Li, Zhibao Lv, Jiangbin Liu, Zhou Chen, Kuiran Dong, Zhuoying Wang

Advanced Science· Volume 12· Issue 39

Abstract

Abstract The tumor ecosystem heterogeneity of papillary thyroid carcinoma (PTC) is poorly characterized in children and young adult patients (CAYA‐PTC). In this study, single‐cell RNA sequencing is used to profile transcriptomes from the paratumor and tumor tissues of 11 patients. Compared to adult, CD4T_Tfh and CD8T_Tex cells are significantly more prevalent in CAYA‐PTC patients. Three phenotypes are identified within the thyrocytes through differentiation trajectory analysis, including normal, BRAF‐like, and Fusion‐like. Notably, the data reveal that CAYA‐PTC patients lack the “mild‐state (BRAF‐like)” malignant thyrocyte population. This variation in differentiation states indicates that PTC cells in CAYA patients rapidly develop into invasive and metastatic forms, whereas in adult patients, this progression occurs gradually over a longer period. Additionally, extracellular matrix cancer‐associated fibroblasts (emCAFs_LAMP5) interact with endothelial cells and thyrocytes, promoting tumor angiogenesis and metastasis more prominently in CAYA patients. Fibroblast activation protein (FAP) expression is high in emCAF_LAMP5 and positively correlated with LAMP5 in CAYA‐PTC tissues. Consequently, 68Ga‐FAPI‐PET emerges as a promising diagnostic method for CAYA patients who are not effectively diagnosed by traditional 18F‐FDG‐PET. Collectively, the findings provide insight into the CAYA‐PTC ecosystem that suggests distinct diagnostic, prognostic, and therapeutic implications compared to adults.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Peptidase Inhibition and Analysis · Thyroid Cancer Diagnosis and Treatment · Galectins and Cancer Biology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Head and Neck Surgery Renji Hospital School of Medicine Shanghai Jiaotong University Shanghai 200001 China

Department of Nuclear Medicine Renji Hospital School of Medicine Shanghai Jiaotong University Shanghai 200001 China

Department of Pathology Ruijin Hospital School of Medicine Shanghai Jiaotong University Shanghai 200001 China

Department of General Surgery Children's Hospital of Shanghai Shanghai Jiao Tong University Shanghai 200333 China

Department of Pediatric Surgery Children's Hospital of Fudan University Shanghai 201102 China

Funding

National Natural Science Foundation of China

References (77)

Show source-provided references
1. 10.1016/j.cell.2014.09.05010.1016/j.cell.2014.09.050 ↗
2. 10.1089/thy.2021.000310.1089/thy.2021.0003 ↗
3. 10.1089/thy.2014.046010.1089/thy.2014.0460 ↗
4. 10.1172/JCI16965310.1172/JCI169653 ↗
5. 10.1016/j.cell.2017.10.04410.1016/j.cell.2017.10.044 ↗
6. 10.1038/s41467-021-26343-310.1038/s41467-021-26343-3 ↗
7. 10.1038/s41467-022-29000-510.1038/s41467-022-29000-5 ↗
8. 10.1038/s41467-022-33907-410.1038/s41467-022-33907-4 ↗
9. 10.1038/s41418-023-01217-x10.1038/s41418-023-01217-x ↗
10. 10.1089/thy.2012.056010.1089/thy.2012.0560 ↗
11. 10.1038/s41591-018-0045-310.1038/s41591-018-0045-3 ↗
12. 10.1172/JCI12867210.1172/JCI128672 ↗
13. Sun Y. · Cell · 2021 · 184
14. 10.1016/j.immuni.2016.10.02110.1016/j.immuni.2016.10.021 ↗
15. 10.1038/s41586-019-0969-x10.1038/s41586-019-0969-x ↗
16. 10.1038/s41467-023-38886-810.1038/s41467-023-38886-8 ↗
17. 10.1038/s41467-022-35209-110.1038/s41467-022-35209-1 ↗
18. 10.1126/science.abe647410.1126/science.abe6474 ↗
19. 10.1016/j.immuni.2019.10.00610.1016/j.immuni.2019.10.006 ↗
20. 10.1038/s41590-020-0706-510.1038/s41590-020-0706-5 ↗
21. 10.1016/j.immuni.2020.07.01210.1016/j.immuni.2020.07.012 ↗
22. 10.1126/sciadv.abn777410.1126/sciadv.abn7774 ↗
23. 10.1016/j.cell.2021.01.02210.1016/j.cell.2021.01.022 ↗
24. 10.1038/s41591-021-01323-810.1038/s41591-021-01323-8 ↗
25. 10.1038/s41421-023-00605-410.1038/s41421-023-00605-4 ↗
26. 10.1038/s43018-023-00599-810.1038/s43018-023-00599-8 ↗
27. 10.1016/j.cell.2019.10.02810.1016/j.cell.2019.10.028 ↗
28. 10.1038/s41586-019-1324-y10.1038/s41586-019-1324-y ↗
29. 10.1038/s41586-019-1326-910.1038/s41586-019-1326-9 ↗
30. 10.1038/nmeth.440210.1038/nmeth.4402 ↗
31. Zhao Q. · Front. Cell Dev. Biol. · 2021 · 9
32. 10.1038/nature1826810.1038/nature18268 ↗
33. 10.1038/s41467-020-19593-010.1038/s41467-020-19593-0 ↗
34. .
35. 10.1038/s41467-023-39762-110.1038/s41467-023-39762-1 ↗
36. 10.1007/s12022-023-09764-210.1007/s12022-023-09764-2 ↗
37. 10.1530/EJE-16-086310.1530/EJE-16-0863 ↗
38. .
39. 10.1038/s43018-022-00411-z10.1038/s43018-022-00411-z ↗
40. 10.7150/thno.6054010.7150/thno.60540 ↗
41. 10.1038/s41580-018-0080-410.1038/s41580-018-0080-4 ↗
42. 10.1158/0008-5472.CAN-21-076110.1158/0008-5472.CAN-21-0761 ↗
43. 10.1016/j.celrep.2018.10.04510.1016/j.celrep.2018.10.045 ↗
44. 10.1038/s41419-020-03070-z10.1038/s41419-020-03070-z ↗
45. 10.1002/cac2.1227410.1002/cac2.12274 ↗
46. Han P.‐Z. · JCI Insight · 2024 · 9
47. 10.7150/thno.6947510.7150/thno.69475 ↗
48. 10.1148/radiol.22074910.1148/radiol.220749 ↗
49. 10.1148/radiol.21243010.1148/radiol.212430 ↗
50. 10.1007/s00259-022-06067-210.1007/s00259-022-06067-2 ↗
51. 10.1158/1078-0432.CCR-23-198310.1158/1078-0432.CCR-23-1983 ↗
52. 10.1089/thy.2019.080210.1089/thy.2019.0802 ↗
53. 10.1210/clinem/dgad45810.1210/clinem/dgad458 ↗
54. 10.1038/s41590-022-01253-810.1038/s41590-022-01253-8 ↗
55. 10.1016/j.cell.2021.11.00710.1016/j.cell.2021.11.007 ↗
56. 10.1016/j.immuni.2021.11.00310.1016/j.immuni.2021.11.003 ↗
57. 10.1016/j.jhep.2023.12.01510.1016/j.jhep.2023.12.015 ↗
58. 10.1038/s41577-022-00796-z10.1038/s41577-022-00796-z ↗
59. 10.1172/JCI13990510.1172/JCI139905 ↗
60. 10.1016/j.immuni.2021.12.00710.1016/j.immuni.2021.12.007 ↗
61. 10.1172/JCI15057810.1172/JCI150578 ↗
62. 10.1038/s41467-023-41880-910.1038/s41467-023-41880-9 ↗
63. 10.1038/s41586-019-1325-x10.1038/s41586-019-1325-x ↗
64. 10.1016/j.cell.2023.02.02110.1016/j.cell.2023.02.021 ↗
65. 10.1016/j.ccell.2022.05.00410.1016/j.ccell.2022.05.004 ↗
66. Liu Z. · Cancer Cell · 2023 · 41
67. 10.1172/JCI16567310.1172/JCI165673 ↗
68. 10.1016/j.immuni.2023.06.00710.1016/j.immuni.2023.06.007 ↗
69. 10.1038/s41467-022-28120-210.1038/s41467-022-28120-2 ↗
70. 10.1038/nrendo.2011.14210.1038/nrendo.2011.142 ↗
71. 10.1136/gutjnl-2020-32292410.1136/gutjnl-2020-322924 ↗
72. 10.1016/j.ccell.2021.09.00310.1016/j.ccell.2021.09.003 ↗
73. 10.1038/ncb347810.1038/ncb3478 ↗
74. 10.1093/jnci/djac22610.1093/jnci/djac226 ↗
75. 10.2967/jnumed.119.22796710.2967/jnumed.119.227967 ↗
76. 10.2967/jnumed.118.21591310.2967/jnumed.118.215913 ↗
77. 10.1148/radiol.21142410.1148/radiol.211424 ↗